G T250
Pill imprint G T250 has been identified as Ticlopidine 250 mg.
Ticlopidine is used in the treatment of cerebral thrombosis/embolism and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy.
Ticlopidine 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Ticlopidine Images
- Imprint:
-
G
T250 - Strength:
- 250 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Platelet aggregation inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Par Pharmaceutical Inc.
- National Drug Code (NDC):
- 49884-0599
Advertisement
More Ticlopidine resources
- Ticlopidine (Wolters Kluwer)
- ticlopidine (Cerner Multum)
- ticlopidine (Micromedex) - Includes Dosage Information
- Ticlopidine Hydrochloride (AHFS DI)
- Ticlopidine (FDA)
- Ticlopidine Hydrochloride (Wolters Kluwer)
Search Again
